treatment [ftcn]
Challenge [clna]
Hypercholesterolaemia [dsyn]
Primary [qlco]
secondary [neop]
prevention trials [resa]
high cholesterol level [fndg]
Plasma [bdsu]
Proven [qlco]
Cholesterol-lowering drug [phsu]
treatment [ftcn]
coronary heart disease [dsyn]
Morbidity [qnco]
Mortality [qnco]
Life [idcn]
Degree [qlco]
Benefit [qnco]
Derived [qlco]
treatment [ftcn]
APPEAR [qlco]
Proportional [qlco]
Percentage [qnco]
reduction [npop]
plasma cholesterol [lbpr]
Regression [patf]
Reduced [qlco]
progression [patf]
Atherosclerosis [dsyn]
account [idcn]
Derived [qlco]
Lipid-lowering therapy [topp]
Drug [phsu]
Direct [qlco]
Mechanisms [ftcn]
Operative [tmco]
Including [ftcn]
Reduced [qlco]
Atherogenesis [patf]
Macrophages [cell]
Improved [qlco]
vascular [bpoc]
Vasodilation [phsf]
Reduced [qlco]
Specific [qlco]
treatment [ftcn]
Cholesterol, LDL [bacs, strd]
Global [spco]
coronary heart disease [dsyn]
coronary heart disease [dsyn]
Coronary heart disease risk [inpr]
Angiographies [diap]
Clinical Data [inpr]
Support [medd]
Lipid-lowering therapy [topp]
Patients [podg]
coronary heart disease [dsyn]
Coronary heart disease risk [inpr]
symptoms [ftcn]
CLINICAL SIGNS [fndg]
Atherosclerosis [dsyn]
Selection Criteria [qlco]
Cholesterol, LDL [bacs, strd]
lowering [spco]
Efficacy [qlco]
coronary heart disease [dsyn]
Morbidity [qnco]
Mortality [qnco]
Survival [acty]
Benefits [qnco]
Adverse Effect [fndg]
Concomitant [tmco]
Metabolic Diseases [dsyn]
Diabetes [dsyn]
TOLERABILITY [resa]
Safety [hcpp]
Simple [qlco]
Dose [qnco]
Schedule [inpr]
Cost Effectiveness [qnco]
Refractory [ftcn]
Hypercholesterolaemia [dsyn]
Combination Therapy [topp]
Required [ftcn]
Secondary Prevention [topp]
Primary Prevention [topp]
Coronary heart disease risk [inpr]
Cost Effectiveness [qnco]
